The Director, US Commercial Pipeline and Planning for Revolution Medicines will lead the NSCLC commercial strategy, manage planning processes, and drive execution against business objectives in a cross-functional environment.

The Associate Director will develop and execute global pricing strategies across the portfolio, lead pricing frameworks and advanced analytics, and collaborate cross-functionally to align pricing with business objectives.

The Senior Financial Analyst/Finance Manager will manage clinical trial accruals, financial reporting, and support audits while collaborating with cross-functional teams.

The Manager of Document Management will oversee controlled documents lifecycle, ensuring compliance with regulations and managing change requests across teams.

The Director will oversee stability management, designing, and evaluating studies, and ensuring compliance with ICH and GMP standards in clinical oncology drug development.

The Associate Director, Learning & Engagement will lead the design and implementation of innovative learning initiatives and support employee engagement across the organization, collaborating closely with HR and various functional teams.

The Director, U.S. Forecasting will develop and execute forecasting models for oncology products, manage cross-functional collaborations, and enhance forecasting processes and tools.

Responsible for statistical design, analysis, and reporting of oncology clinical studies, collaborating across functions to ensure timely and accurate deliverables.

The role involves leading Organizational Development to enhance team performance and organizational health, emphasizing leadership effectiveness and strategic growth.

The Director of Program Management will lead cross-functional teams in the clinical development of RAS(ON) inhibitors, ensuring efficient execution of the development strategy and managing project risks and stakeholder communications.

The intern will support the Biophysics and Protein Sciences Group by conducting small-scale expression and purification experiments to improve protein yield and quality.

The Senior Director, Commercial Project Management will lead global commercial project teams, ensuring clarity and progress in complex initiatives, while shaping project management capabilities and driving strategic execution within the organization.

The Associate Director will manage program execution for RAS(ON) inhibitors, collaborating with teams to ensure clarity, strategy execution, and effective communication for clinical development.

Lead the intellectual property strategy for a complex patent portfolio, focusing on global patent prosecution, disputes, and advising senior leadership on IP risks and strategies.

The Executive Director, Patents will lead the IP strategy for a complex patent portfolio, managing prosecution and disputes while advising senior leadership on competitive risks and opportunities.

The Safety Scientist provides safety science and pharmacovigilance support for clinical trials, including medical reviews and safety data evaluations.

Lead analytics and insights for lung cancer assets, shaping strategy through data insights and team leadership in a biotech environment.

The Executive Business Director, NSCLC leads a regional team to drive sales of oncology products, fostering key relationships and achieving performance targets while mentoring team members and collaborating with cross-functional partners.

The Senior Safety Scientist provides safety science and pharmacovigilance support for clinical studies, overseeing safety reports, protocols, and risk management strategies for oncology products.

The Biomarker Strategic Engagement Lead will manage partnerships with labs and pathologists to enhance RAS biomarker testing for oncology. Responsibilities include overseeing strategic objectives, supporting engagement initiatives, and acting as a subject matter expert in biomarker partnerships.